Close Menu

NEW YORK (GenomeWeb) – Genomic services contract research organization Genewiz and Hy Laboratories today announced a partnership to develop diagnostic panels to characterize the gut microbiome in patients with obesity and diabetes.

The multiyear project seeks to stratify patients with diabetes and obesity for bariatric surgery or alternative treatments. Obesity and diabetes are closely related to the function and population of the gut microbiome, the firms said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.